Kincell is a technology-forward contract development and manufacturing organization (CDMO) that streamlines analytical development, process development, CMC consulting and early-stage GMP cell therapy manufacturing. Our focus is on developing and manufacturing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs. For more information, please visit our website at www.kincellbio.com.
Location: United States, Florida, Gainesville
Total raised: $22M
Founded date: 2023
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.05.2025 | - | $22M | - |
Mentions in press and media 5
| Date | Title | Description |
| 15.05.2025 | Kincell Bio Raises $22M in Funding | Kincell Bio, a Research Triangle Park, NC- and Gainesville, FL-based contract development and manufacturing organization (CDMO), raised $22M in funding. The round was led by NewSpring Capital through its dedicated healthcare strategy, NewSp... |
| 20.06.2024 | Azzur Group Appoints Nick Mazzucca as Vice President of Sales and Marketing | HATBORO, Pa., June 20, 2024 /PRNewswire/ -- Azzur Group, a comprehensive solutions provider for life science innovators in the regulated space, is excited to announce the appointment of Nick Mazzucca as Vice President of Sales and Marketing... |
| 26.07.2023 | Kincell Bio Closes $36M Funding Round | GAINESVILLE, FL, Kincell Bio, a contract development and manufacturing organization focused on cell therapies, announced a $36 million funding round. >> Click here for more funding data on Kincell Bio >> To export Kincell Bi... |
| - | Kincell Bio | “Home - Kincell Bio” |
| - | Kincell Bio | “A trusted CDMO partner with deep experience in autologous & allogeneic therapies, Kincell Bio is your expert partner for early-phase cell therapy development” |